Myriad Genetics | MYGN - Stock


Myriad Genetics reported $30.6M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Agilent USD 1.09B 30M Mar/2026
Becton, Dickinson and Co. USD 3.32B 41M Jun/2026
Bio-Rad Laboratories USD 780.6M 10.1M Jun/2026
Bruker USD 1.12B 1.4M Jun/2026
Danaher USD 3.26B 652M Jun/2026
Illumina USD 629M 18M Jun/2026
J&J USD 15.14B 561M Jun/2026
Mettler Toledo International USD 411.56M 6.74M Jun/2026
Myriad Genetics USD 30.6M 2.7M Jun/2026
OraSure Technologies USD 30.31M 753K Mar/2026
Pacific Biosciences Of California USD 61.08M 10.06M Jun/2026
Quest Diagnostics USD 233M 8M Jun/2026
Quidel USD 618.9M 7.4M Jun/2026
Repligen USD 186.6M 7.35M Jun/2026
Revvity USD 378.5M 9M Jun/2026
Standard Biotools USD 18.59M 1.39M Mar/2026
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Veracyte USD 22.66M 1.24M Jun/2026
Waters USD 1.38B 119M Jun/2026